European Medicines Agency suspends some generics over flawed studies

All medicines authorised in the EU on the basis of bioequivalence studies conducted by Panexcell will be suspended from the market.
All medicines authorised in the EU on the basis of bioequivalence studies conducted by Panexcell will be suspended from the market.